Trials / Unknown
UnknownNCT01441739
Intestinal Failure in Necrotising Enterocolitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Necrotizing enterocolitis (NEC) is a severe gastrointestinal disorder with high morbidity and mortality (20-40%), affecting predominantly premature neonates. NEC continues to present a diagnostic challenge to clinicians. The initial clinical manifestations of NEC are non-specific and indistinguishable from other gastrointestinal disorders and sepsis. The first goal of this study is to find and evaluate tests to diagnose NEC at an early stage. For the development of new diagnostic markers, the investigators require knowledge of pathophysiological processes that underlie NEC, which still remain unclear. Therefore, the second goal of this study is to elucidate the etiology of NEC. Furthermore, understanding of the pathophysiology of NEC can offer the possibility to develop new therapeutical treatments.
Conditions
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2011-09-28
- Last updated
- 2013-12-18
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01441739. Inclusion in this directory is not an endorsement.